Common Contracts

CHROMOCELL THERAPEUTICS CORPORATION 2023 Equity Incentive Plan Stock Option Agreement

Stock Option Agreement • April 15th, 2024 • Chromocell Therapeutics Corp • Biological products, (no disgnostic substances) • Delaware

• Contract Type
  Stock Option Agreement
• Filed
  April 15th, 2024
• Company
  Chromocell Therapeutics Corp
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  Delaware

This Stock Option Agreement and the associated grant award information (the “Customizing Information”), which Customizing Information is provided in written form (the “Stock Option Schedule”) or is available in electronic form from the record keeper for the Chromocell Therapeutics Corporation 2023 Equity Incentive Plan, as amended and in effect from time to time (the “Plan”), made as of the date shown as the “Grant Date” in the Customizing Information (the “Grant Date”) by and between Chromocell Therapeutics Corporation, a Delaware corporation (the “Company”), and the individual identified in the Customizing Information (the “Optionee”). This instrument and the Customizing Information are collectively referred to as the “Option Agreement.”

LIPELLA PHARMACEUTICALS INC. Amended and Restated 2020 Stock Incentive Plan Stock Option Agreement

Stock Option Agreement • November 28th, 2022 • Lipella Pharmaceuticals Inc • Pharmaceutical preparations • Delaware

• Contract Type
  Stock Option Agreement
• Filed
  November 28th, 2022
• Company
  Lipella Pharmaceuticals Inc
• Industry
  Pharmaceutical preparations
• Jurisdiction
  Delaware

This Stock Option Agreement and the associated grant award information (the “Customizing Information”), which Customizing Information is provided in written form as the Stock Option Schedule or is available in electronic form from the recordkeeper for the Lipella Pharmaceuticals Inc. Amended and Restated 2020 Stock Incentive Plan, as amended and in effect from time to time (the “Plan”), made as of the date shown as the “Grant Date” in the Customizing Information (the “Grant Date”) by and between Lipella Pharmaceuticals Inc., a Delaware corporation (the “Company”), and the individual identified in the Customizing Information (the “Optionee”). This instrument and the Customizing Information are collectively referred to as the “Option Agreement.”

IRON MOUNTAIN INCORPORATED Iron Mountain Incorporated 2014 Stock and Cash Incentive Plan

Stock Option Agreement • February 13th, 2020 • Iron Mountain Inc • Real estate investment trusts • Massachusetts

• Contract Type
  Stock Option Agreement
• Filed
  February 13th, 2020
• Company
  Iron Mountain Inc
• Industry
  Real estate investment trusts
• Jurisdiction
  Massachusetts

This Stock Option Agreement and the associated grant award information (the “Customizing Information”), which Customizing Information is provided in written form or is available in electronic form from the record keeper for the Iron Mountain Incorporated 2014 Stock and Cash Incentive Plan, as amended and in effect from time to time (the “Plan”), made as of the date shown as the “Grant Date” in the Customizing Information (the “Grant Date”) by and between Iron Mountain Incorporated, a Delaware corporation (the “Company”), and the individual identified in the Customizing Information (the “Optionee”). This instrument and the Customizing Information are collectively referred to as the “Option Agreement.”